Likewise, EGCG at concentrations of 20 μM or more was found to inhibit, by about half, the expression and activity of MMP-2 and MMP-9 in human renal carcinoma cells (786-0 and ACHN) and thus reduce their migratory and invasive potential [55]. This evidence concerns the gene MMP9 and renal carcinoma.